ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $422,000 | +66.8% | 4,545 | +6.9% | 0.01% | +55.6% |
| Q3 2021 | $253,000 | -14.5% | 4,251 | -2.1% | 0.01% | -18.2% |
| Q2 2021 | $296,000 | -1.7% | 4,343 | 0.0% | 0.01% | -8.3% |
| Q1 2021 | $301,000 | -18.2% | 4,343 | -9.3% | 0.01% | -20.0% |
| Q4 2020 | $368,000 | -5.4% | 4,790 | -8.0% | 0.02% | -16.7% |
| Q3 2020 | $389,000 | +4.6% | 5,207 | -11.8% | 0.02% | -5.3% |
| Q2 2020 | $372,000 | – | 5,904 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |